Country Club Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,636
Closed -$638K 321
2024
Q3
$638K Sell
7,636
-561
-7% -$42.8K 0.04% 236
2024
Q2
$564K Buy
8,197
+97
+1% +$6.47K 0.04% 239
2024
Q1
$593K Sell
8,100
-521
-6% -$40.1K 0.04% 230
2023
Q4
$700K Sell
8,621
-34
-0.4% -$2.65K 0.05% 220
2023
Q3
$653K Sell
8,655
-209
-2% -$16.1K 0.05% 214
2023
Q2
$674K Sell
8,864
-111
-1% -$8.85K 0.05% 211
2023
Q1
$731K Buy
8,975
+147
+2% +$12.2K 0.06% 210
2022
Q4
$758K Sell
8,828
-174
-2% -$13.8K 0.07% 191
2022
Q3
$568K Buy
9,002
+45
+0.5% +$2.84K 0.05% 198
2022
Q2
$560K Buy
8,957
+2,843
+46% +$176K 0.05% 197
2022
Q1
$365K Buy
+6,114
New +$391K 0.03% 211

Other funds holding GILD

Country Club Bank's GILD Position: Q4 2024 in Review

Country Club Bank sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 7,636 shares — an estimated $638K sold.

Country Club Bank first reported a position in GILD in Q1 2022 and held it in 11 quarters. The position peaked at $758K in Q4 2022. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Country Club Bank reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Country Club Bank sold 7,636 Gilead Sciences shares in Q4 2024, an estimated $638K.
  • Country Club Bank first reported a position in Gilead Sciences in Q1 2022 and held it in 11 quarters.
  • Country Club Bank's Gilead Sciences position peaked at $758K in Q4 2022.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Country Club Bank's 13F filing for Q4 2024, filed 27 Jan 2025.